first glp 1 drug Evolution of GLP‐1 Receptor Agonists for Diabetes Treatment Use of GLP-1 drugs early
Description
Differences in study design, together with the relatively small number of participants receiving combined treatment, may limit the ability to detect synergistic effects
doi: 10.1152/ajpendo.1982.242.3.E206 87 ZieglerRBellwinkelSSchmidtchenDMinneH
Hsu CY, McCulloch CE, Iribarren C et al
doi: 10.1016/j.cmet.2018.03.001
Erythema and swelling along with nodular indurations and lipodystrophy represent the main injection-site reactions reported [46]
